No more business as usual: Pfizer, Bayer and Sanofi step up actions against Russia amid growing pressure to exit
As the Russian invasion of Ukraine enters its third week, pharma — just like a host of other industries — is feeling a growing pressure to get serious about exiting Russia.
Pfizer, Bayer and Sanofi were among the first to declare dramatic action on that score, formalizing commitments that their respective CEOs have communicated in recent days into written statements.
Biopharma companies across the board have joined an international chorus of voices condemning Russia’s attack and supporting Ukrainians. But most have stuck with either internal (focusing on their own employees) or humanitarian efforts (for instance, donating essential medicines to Ukraine) rather than business or economic ones.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
